Breaking News, Financial News

Financial Report: PPD 2Q

Development revenue for the quarter was $333.8 million (+1%). Discovery sciences revenue was $7.7 million, compared to $0.2 million in 2Q09.

PPD 2Q

2Q Revenues: $369.9 million (+4%)

2Q Earnings: $21.0 million (-64%)

YTD Revenues: $716.7 million (flat)

YTD Earnings: $38.2 million (-62%)

Comments:
Development revenue for the quarter was $333.8 million (+1%). Discovery sciences revenue was $7.7 million, compared to $0.2 million in 2Q09. Revenue for this segment included a $7.5 million milestone payment from Takeda related to pricing approvals for Nesina (alogliptin) in Japan. Gross authorizations for the quarter totaled $610.5 million. Backlog at June 30, 2010, was $3.2 billion. Contract cancellations and adjustments were $145.3 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters